CLINICAL_TRIALS
trial_result
· 2022-12-23
Clinical Trial Update: Eszopiclone for the Treatment of Posttraumatic Stress Disorder [Phase 4]
Summary
Phase 4 trial update assessing eszopiclone for posttraumatic stress disorder has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rush University Medical Center | Conditions: Posttraumatic Stress Disorders | Phase 4 | Status: COMPLETED | Results posted: 2022-12-23